CoChat

Dual regulation of vascular endothelial growth factor bioavailability by genetic and proteolytic mechanisms.

Open access
Houck, K.A., Leung, D.W., Rowland, A.M., Winer, J, Ferrara, N · 1992 · Journal of Biological Chemistry

The DOI matches its Crossref record; 53 of the 54 references it cites were found in a registry or an index.

Abstract

The vascular endothelial growth factor (VEGF) family encompasses four polypeptides that result from alternative splicing of mRNA. We have previously demonstrated differences in the secretion pattern of these polypeptides. Stable cell lines expressing VEGFs were established in human embryonic kidney CEN4 cells. VEGF121, the shortest form, was secreted and freely soluble in tissue culture medium. VEGF189 was secreted, but was almost entirely bound to the cell surface or extracellular matrix. VEGF165 displayed an intermediary behavior. Suramin induced the release of VEGF189, permitting its characterization as a more basic protein with higher affinity for heparin than VEGF165 or VEGF121, but with similar endothelial cell mitogenic activity. Heparin, heparan sulfate, and heparinase all induced the release of VEGF165 and VEGF189, suggesting heparin-containing proteoglycans as candidate VEGF-binding sites. Finally, VEGF165 and VEGF189 were released from their bound states by treatment with plasmin. The released 34-kDa dimeric species are active as endothelial cell mitogens and as vascular permeability agents. We conclude that the bioavailability of VEGF may be regulated at the genetic level by alternative splicing that determines whether VEGF will be soluble or incorporated into a biological reservoir and also through proteolysis following plasminogen activation.

Overview

Integrity signals

Registry

Crossref · 10.1016/s0021-9258(18)35712-0

Cites

53 of 53 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Verification

Claims the paper makes

We couldn’t retrieve this paper’s full text, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Citations

Cites

Show all 53 references

Research works printed but not linked: 6

  1. Stanley, 1991, Mol. Cell. Biol., 11, 3399
  2. Cachianes, 1992, Technique
  3. Andreason, 1988, BioTechniques, 6, 650
  4. Papkoff, 1989, Mol. Cell. Biol., 9, 3377
  5. Zarnegar, 1989, Cancer Res., 49, 3314
  6. Ferrara, 1991, 9, 127

Cited by

See all 1,127

Metadata

Authors
Houck, K. A., Leung, D. W., Rowland, A. M., Winer, J., & Ferrara, N.
Affiliations
Genentech (US)
Venue
Journal of Biological Chemistry
Publisher
Elsevier BV
Published
1992-12
Volume
267
Issue
36
Pages
26031-26037
ISSN
0021-9258 (ISSN-L)
OpenAlex
W1624346216
Cited by
1,127
References
54
Citations by year
2026: 4 · 2025: 13 · 2024: 7 · 2023: 7 · 2022: 16 · 2021: 24 · 2020: 15 · 2019: 15 · 2018: 19 · 2017: 13 · 2016: 19 · 2015: 31 · 2014: 34 · 2013: 56 · 2012: 39
FWCI
6.36
Type
journal article
Language
en
Open access
Licence
Locations
  • Journal of Biological Chemistry (publishedVersion, cc-by)
  • PubMed (publishedVersion)
Topics
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Angiogenesis and VEGF in Cancer
  • Health Sciences › Medicine › Oncology › Lymphatic System and Diseases
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Fibroblast Growth Factor Research
Keywords
vascular endothelial growth factor, VEGF isoforms, VEGF165, VEGF189, VEGF121, alternative splicing, VEGF secretion, heparin binding, heparan sulfate, heparinase, plasmin, proteolysis, vascular permeability, extracellular matrix binding
MeSH terms
Amino Acid Sequence, Biological Assay, Cell Line, Chromatography, Affinity, Chromatography, Ion Exchange, Cysteine, Embryo, Mammalian, Genetic Vectors, Heparin, Heparan Sulfate, Heparitin Sulfate, Humans, Kidney, Lymphokines, Methionine, Molecular Sequence Data, Molecular Weight, Protein-Tyrosine Kinases, Receptors, Mitogen, RNA, Messenger, Suramin, Transfection, Endothelial Growth Factors, Alternative Splicing, Receptors, Vascular Endothelial Growth Factor, Vascular Endothelial Growth Factors, Vascular Endothelial Growth Factor A

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Dual regulation of vascular endothelial growth factor bioavailability by genetic and proteolytic mechanisms. https://app.cochat.ai/papers/10.1016/s0021-9258(18)35712-0
The paper
Houck, K. A., Leung, D. W., Rowland, A. M., Winer, J., & Ferrara, N. (1992). Dual regulation of vascular endothelial growth factor bioavailability by genetic and proteolytic mechanisms. Journal of Biological Chemistry. https://doi.org/10.1016/s0021-9258(18)35712-0

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.